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Abstract 
Arginine supplementation has been shown to induce endothelium-dependent vasodilation and enhance exercise 
performance via increasing nitric oxide (NO) production in patients with various cardiovascular diseases. The purpose 
of this study was to determine the effect of short-term arginine supplementation on vasodilation and performance in 
intermittent anaerobic exercise in well-trained male athletes. Ten elite male college judo athletes completed 2 trials in a 
randomized crossover and placebo-controlled design. All subjects received 6 g/day arginine (ARG trial) or placebo 
(CON trial) for 3 days before undertaking an intermittent anaerobic cycling test. In each exercise test, the subjects 
alternated 20-sec all-out exercise and 15-sec rest periods for 13 sets on a cycle ergometer. Vasodilation was measured 
using photoplethysmography in pre-supplementation, pre-exercise, and 0, 3, 6, 10, 30, and 60 min of post-exercise. The 
2 trials had similar vascular reflection index and heart rate before the exercise test. Immediately after exercise 
reflection index of both trials was significantly reduced, then it showed a trend of decrease at 6 and 10 min after 
exercise (p<0.1). However, no significant difference in refection index and heart rate was found at any the same time 
point between the trials. There was no significant difference in power drop of each set and the decrements of peak and 
average power between the trials. This study suggested that the short-term arginine supplementation had no effect on 
exercise-induced vasodilation and performance in intermittent anaerobic tests in well-trained male judo athletes. 
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Introduction 
Arginine has the potential effect on increasing 
endothelium-dependent vasodilation and improving exercise 
performance by serving as a precursor for nitric oxide (NO) 
synthesis [1]. Oral arginine supplementation has been reported 
to increase endothelium-dependent vasodilation in the forearm 
in patients with hypercholesterolemia [2], coronary artery 
atherosclerosis [3,4], essential hypertension [5] and chronic 
heart failure [6,7]. Arginine administration intravenously could 
also improve exercise-induced blood flow in the calf in 
subjects with chronic heart failure [8]. Arginine administration 
also improved endothelium-dependent vasodilation in healthy 
elderly and young subjects [9,10]. In addition, NO could 
increase  exercise-induced  vasodilation in healthy sedentary  
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adults [11]. 
Arginine could also improve exercise capacity in patients 
with various cardiopulmonary diseases. It has been shown that 
oral arginine supplementation  improved time  to exhaustion 
and maximal oxygen consumption in patients with coronary 
artery diseases [4,12] and angina pectoris [13,14]. A 4-week 
oral arginine in combination with handgrip training has been 
shown to enhance maximal handgrip work in patients with 
chronic heart failure, by increasing endothelium-dependent 
vasodilation and blood flow in the forearm [6]. The evidences 
suggested that arginine administration orally or intravenously 
could also significantly reduce the accumulation of plasma 
lactate and ammonia, the metabolites may result in muscular 
fatigue, after endurance exercise or maximal graded exercise 
in healthy subjects [15-17]. Therefore, arginine 
supplementation could improve exercise capacity via 
attenuating exercise-induced accumulation [18]. 
The ergogenic effect of arginine supplementation in healthy 
subjects and well-trained athletes is still inconclusive. It has 
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been suggested that oral supplementation of arginine combined 
with glycine and alpha-ketoisocaproic acid (GAKIC) prior to 
exercise may increase total and average power output in 
exhaustive anaerobic exercise in healthy young males [19,20]. 
Nevertheless, the role of arginine in these studies was difficult 
to identify due to the synergistic effect of the two other 
compounds on delaying muscular fatigue. 
Since arginine could increase exercise-induced vasodilation 
and reduce the accumulation of the exercise-induced 
metabolites that may induce muscular fatigue, we 
hypothesized that oral supplementation of arginine may 
improve exercise performance in well-trained athletes. The 
purpose of this study was to determine whether short-term 
arginine supplementation could enhance vasodilation and 
prevent performance decline in intermittent anaerobic exercise 
in well-trained male athletes. 
Methods 
Subjects 
Ten elite male judo athletes were recruited from National 
Taiwan College of Physical Education. The subjects were 
matched by similar body weight to avoid the potential 
difference in exercise performance and supplementation 
dosage. Exclusive criterion was consisted of known 
cardiovascular disease risks, musculoskeletal injuries and 
abnormally plasma arginine concentrations in the preliminary 
study. All subjects were asked to abstain from any supplements 
at least 3 months prior to the present study. Each athlete has 
received regular judo training for at least 3 years and 
participated in the national or international contests. 
During the study period, all subjects were asked to maintain 
their regular training programs and diets. Each subject 
consumed the identical food on the day prior to the 2 trials. 
After the experimental procedures and possible risk were 
explained by the researchers, the subjects gave their written 
informed consent. The study protocol was approved by the 
Human Subject Committee of National Taiwan College of 
Physical Education. 
 
Experimental design 
 
 
 
 
 
 
 
 
 
Figure. 1. The experimental protocol of intermittent anaerobic exercise 
test and cardiovascular function measurement. ↑ : 
photoplethysmography. 
 
This study used a randomized crossover and 
placebo-controlled design. All subjects completed two trials, 
ARG and CON. The 2 trials were separated by a 4-day 
washout period. In the ARG trial, the subjects consumed 6 
g/day arginine tablets (General Nutrition Corp., Pittsburgh, PA, 
USA) for 2 days. After an overnight fasting, each subject 
received the third dose of 6 g arginine in the morning, 
undertook the intermittent anaerobic exercise test 60 min after 
supplementation. In the CON trial, the subjects consumed the 
equal number of tablets containing starch. The experimental 
protocol is shown in Fig. 1. 
 
Intermittent anaerobic exercise test 
The test was designed to mimic the actual judo competition. 
Each subject practiced the same test at least once prior to the 
study. The subjects alternated 20-sec all-out exercise and 
15-sec rest periods for 13 sets on a Monark cycle ergometer 
(894E, Monark, Varberg, Sweden). There was a 1-min rest 
after the 9th set to simulate the rest in the actual competition. 
The ergometer resistance was set at 0.05 kp/kg BW. The 
subjects were vocally encouraged to pedal as fast as possible 
by the researchers. In the 15-sec rest periods, the resistance 
was removed and the subject sustained pedaling at 60 rpm. The 
peak power, average power, and power drop of each set was 
collected through all sprints. The following equation was used 
to calculate power drop in each sprint set [21]. 
 
Power drop (%) = (peak power – lowest power) / peak power 
× 100 
The decrements of peak and average power were used to 
represent the decline between total and maximal work of the 
test. The following equations were used to calculate the 
decrements of peak and average power, respectively [22]. 
 
Peak power decrement (%) = 100 – [total peak power / 
(maximal peak power × 13 sets)] × 100 
Average power decrement (%) = 100 – [total average power / 
(maximal average power × 13 sets)] × 100 
 
Measurement of cardiovascular function 
It has been shown that transmission of infrared light through 
the finger is proportional to blood volume. The transmission 
measured by photoplethysmography gives a digital volume 
pulse (DVP). The DVP exhibits a characteristic notch or 
inflection point that can be expressed as percent maximal DVP 
amplitude (reflection index). Reflection index of pressure 
wave reflection was derived form the DVP and used to 
examine endothelium-dependent vasodilation. It has been 
reported that vasodilators such as glyceryl trinitrate produced 
marked changes in pulse waveform with a decrease in 
reflection index [23]. In this study reflection index and heart 
rate was determined from the right index finger by 
photoplethysmography (Pulse Trace PT1000, Micro Medical, 
Rochester, England). The data was collected before 
supplementation and exercise, and 0, 3, 6, 10, 30, and 60 min 
after exercise before blood samplings. 
 
Statistical analysis 
All data was expressed as means ± SEM. Changes in 
reflection index and heart rate were analyzed by a two-way 
analysis of variance (ANOVA) with repeated measures. The 
differences in cardiovascular function parameters among 
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different time points were analyzed by post hoc Tukey’s test. 
The cardiovascular parameters at the same time point, power 
drops in each set and power decrements between trials were 
analyzed by Student’s paired t-test. The analysis was 
performed with SPSS for Windows 10.0 (SPSS Inc., Chicago, 
IL, USA). A p-value less than .05 was considered statistically 
significant. 
Results 
The subjects were 20.2 ± 0.6 years old. The height was 1.72 
± 0.02 m. The body weight in the ARG and CON trials was 
73.3 ± 2.1 kg and 73.6 ± 2.0 kg, respectively. The body weight 
was not significantly different between the 2 trials. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Vascular reflection index at each time point in ARG (■) and 
CON (□) trials. #p<.05 vs. 60 min in ARG trial; †p<.05 vs. 
60 min in CON trial. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Heart rate at each time point in ARG (■) and CON (□) 
trials. #p<.05 vs. 60 min in ARG trial; †p<.05 vs. 60 min in 
CON trial. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Power drop in each set of intermittent anaerobic exercise 
in ARG (■) and CON (□) trials. 
 
Vascular reflection index, an indicator of 
endothelium-dependent vasodilation, at each time point in 
ARG and CON trials is shown in Fig. 2. Reflection index 
showed a significant time effect (p<.001). Before exercise, no 
significant difference was found between the ARG (85.0 ± 3.6 
%) and CON (83.6 ± 2.9 %) trials. Immediately after exercise, 
the reflection index of ARG and CON significantly declined to 
32.8 ± 4.3 and 30.8 ± 4.0 %, respectively. In ARG trial, there 
was a trend of decrease from 3 min to 30 min after exercise 
compared to pre-exercise (p= .058-.077). In CON trial, 
reflection index at 3 min after exercise (40.6 ± 4.7 %) was 
significantly lower than pre-exercise, and showed a trend of 
decease at 6 and 10 min after exercise (p= .052-.078). 
Heart rate at each time point in the ARG and CON trials is 
displayed in Fig. 3. Heart rate showed a significant time effect 
(p<.001). Both trials had similar heart rate before exercise 
(ARG: 51.6 ± 2.2; 53.1 ± 2.4 bpm). Heart rates remained 
significantly higher throughout the post-exercise period 
compared to the pre-exercise level. Nevertheless, no 
significant difference was found between the 2 trials at any 
time point. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Power decrement of intermittent anaerobic exercise in ARG 
(■) and CON (□) trials. 
 
The peak and average power of the intermittent anaerobic 
exercise has been published elsewhere [24]. The 2 trials had 
similar peak power and average power in each set. The power 
drop of each sprint set in ARG and CON trials is shown in Fig. 
4. Power drops in both trials were 22.4-31.2% in all sets. There 
was no significant difference in power drops between the 2 
trials in any set. Figure 5 shows the decrements of peak and 
average power in both trials. No significant difference in the 
decrements of peak power (ARG: 29.0 ± 4.9%; CON: 35.1 ± 
4.5%) and average power (ARG: 28.0 ± 4.3%; CON: 28.6 ± 
3.4%). 
Discussion 
The results of this study suggested that short-term arginine 
supplementation had no effect on exercise-induced 
vasodilation and performance in intermittent anaerobic 
exercise in well-trained male judo athletes. 
Our results showed that power drop in each set and power 
decrement of the intermittent anaerobic exercise test was 
similar in ARG and CON trials. The exercise protocol was 
used to simulate the judo training and competition pattern of 
these elite athletes. Similarly, it has been shown that 
supplementation of arginine aspartate for 4 weeks did not 
affect the performance of a graded maximal cycling test in 
endurance athletes [25]. On the other hand, it has been 
reported that GAKIC, a combination of supplementations 
including arginine, could delay muscle fatigue and sustain 
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work for at least 15 min during intensive anaerobic exercise in 
healthy subjects [20]. Furthermore, GAKIC attenuated the 
decline in mean power during repeated bouts of supramaximal 
exercise in healthy male college students [19]. Nevertheless, 
this effect may result from the combination of the compounds, 
rather than arginine alone. 
Both ARG and CON trials showed exercise-induced 
vasodilation measured by reflection index. However, arginine 
supplementation had no additional effect on exercise-induced 
vasodilation in these well-trained subjects. This result was in 
contrast to previous studies that suggested arginine 
supplementation could improve exercise-induced vasodilation 
in subjects with various cardiovascular diseases [4,8,26]. In 
agreement to our results, supplementation of arginine 20 g/d 
for 4 weeks had no effect on forearm blood flow in healthy 
male [27]. Although arginine administration and regular 
exercise training may have additive effects on improving 
endothelium-dependent vasodilation in chronic heart failure 
subjects [6], it did not provide any additional effect on 
vasodilation in our well-trained subjects. 
Our previous publication has shown that the short-term 
arginine supplementation did not alleviate exercise-induced 
accumulation of plasma lactate and ammonia [24]. This may 
partially result from the lack of additive effect of arginine on 
exercise-induced vasodilation. Further investigations with 
higher dosages or extended supplementation periods are 
warranted in well-trained athletes. 
 
Conclusions 
This study suggested that the short-term arginine 
supplementation had no additive effect on exercise-induced 
vasodilation and performance decline in intermittent anaerobic 
tests in well-trained male athletes. Further research should be 
critically considered with higher dosages, longer 
supplementing durations, or combined with other supplements. 
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